In numerous tests comparing OSDrC® to the performance of conventional tableting machines and reproducibility of the tablets, OSDrC® technology has proven itself better than existing tablet technology.OSDrC® technology and equipment are protected by patents and the overall patent estate is continuously being expanded to fully protect the technology.
In contrast to existing tableting technology, where dividing an enteric coated tablet would lead to performance failure, the OSDrC® rotary tableting technology is capable of producing enteric-coated dividable core tablets that maintain performance after dividing the tablet. Measurements of the API (acetaminophen) release rate from the core in dividable tablets produced on an OSDrC® rotary tableting machine verified that the release characteristics were the same before dividing and after dividing.
Copyright © 2007 SANWA KAGAKU KENKYUSHO CO.,LTD. All rights reserved